Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Total Non-Current Liabilities (2017 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $210.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 7.71% to $210.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $210.2 million through Dec 2025, down 7.71% year-over-year, with the annual reading at $210.2 million for FY2025, 7.71% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $210.2 million at Rhythm Pharmaceuticals, down from $227.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $227.7 million in Q4 2024, with the low at $80.5 million in Q2 2022.
  • Average Total Non-Current Liabilities over 4 years is $152.3 million, with a median of $155.5 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities soared 57.03% in 2023, then fell 7.71% in 2025.
  • Over 4 years, Total Non-Current Liabilities stood at $116.9 million in 2022, then skyrocketed by 38.46% to $161.8 million in 2023, then skyrocketed by 40.71% to $227.7 million in 2024, then decreased by 7.71% to $210.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $210.2 million, $227.7 million, and $166.8 million for Q4 2025, Q4 2024, and Q2 2024 respectively.